Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function
AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Tag: COPD
All
Latest
Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function
AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Read More
Worse COPD, Pneumonia Outcomes at Private Equity Hospitals
Patients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read More
Alpha-1 Drug Candidate Superior to Standard Care
Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Read More
Viz.ai Launches Ai-powered Viz Pulmonary Suite
The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Read More
Why Some Alpha-1 Patients Develop Liver Disease
A newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
Read More
ALA Launches Study to Test Omalizumab for COPD Flare-ups
The COPD-OMA trial will examine if the asthma drug omalizumab (Xolair) benefits COPD patients with sensitivities to indoor allergens.
Read More
WHO Expands Asthma Care in Nepal, Sri Lanka
The initiative focuses on integrating respiratory services into primary healthcare to improve diagnosis and treatment access.
Read More
Tozorakimab Reduces COPD Flare-Ups in Ph3 Trial
The MIRANDA study found tozorakimab significantly lowered the rate of moderate-to-severe respiratory worsening in patients regardless of smoking history or specific white blood cell counts.
Read More
Soy, Legumes May Improve COPD Symptoms
New research suggests isoflavones found in plant-based foods like soy and legumes can reduce inflammation and coughing for patients with COPD.
Read More
Phone-based Training Improves COPD Inhaler Use
A study of Medicare Advantage beneficiaries with COPD shows that pharmacist-led telephone education significantly reduces errors in medication delivery.
Read More
Ai Tool Linked to Higher Flu Vaccine Rates, Fewer Hospitalizations for COPD Patients
A new whitepaper shows that real-time clinical insights for primary care physicians led to higher flu vaccination rates and fewer emergency visits for high-risk populations, including COPD patients.
Read More
Rademikibart Tied to Rapid Lung Function Improvement in Asthma, COPD
Phase 1 study revealed significant FEV1 improvements within 15 min of a single dose of IV rademikibart — an antibody targeting interleukin-4 receptor alpha.
Read More
Tozorakimab Reduced COPD Exacerbations in Ph3 Trials
The monoclonal antibody Tozorakimab showed significant clinical benefit in reducing COPD flare-ups for a broad range of patients, including former and current smokers.
Read More
Wearable Sleep Data Predicts Patient Engagement in Remote COPD Rehab
Sleep metrics from wrist monitors can identify which COPD patients may need more support during pulmonary rehab.
Read More
COPD Breathlessness Action Plans May Reduce Emergency Care
Non-pharmacological strategies like breathing techniques and positioning help COPD patients manage acute episodes and improve confidence.
Read More
COPD Patients Commonly Misuse Medications
Affordability and education are preventing COPD patients from remaining adherent to their prescribed pharmacologies.
Read More
Pulmonary Rehab Awareness Week Advocates for Greater Access
Pulmonary rehabilitation helps improve breathing and quality of life, and comprehensive PR programs deliver physical and emotional benefits for respiratory patients.
Read More
Neighborhood Factors May Increase COPD-related ED Visits, Hospitalizations
Certain neighborhood characteristics, including higher poverty, more uninsured residents, and lower educational attainment, may lead to an increase in COPD-related emergency department visits and hospitalizations.
Read More
High Sugar Drink Intake Linked to COPD Risk
Adults who obtained 10% or more of their daily calories from sugary drinks had a 39% higher likelihood of having COPD compared with those consuming <10%.
Read More
Dry Powder Inhalers Tied to Improved COPD Outcomes, Lower Environmental Impact
Dry powder and soft mist inhalers—which have a lower carbon footprint than metered-dose inhalers (MDIs)—were associated with slightly better clinical outcomes for COPD patients.
Read More
7 Key Components for COPD Pulmonary Rehabilitation
Despite overwhelming evidence of its benefits, pulmonary rehab utilization is surprisingly low among COPD patients. This article will provide 7 key components that RTs can use to effectively design and implement a COPD pulmonary rehab program.
Read More
Quantitative Mucin Index: a New Metric to Monitor Lung Health
The Quantitative Mucin Index (MUCQ) of the Lung analyzes sputum and other lung mucus samples to detect airway mucus abnormalities, assess disease risk, and track disease progression in patients over time.
Read More
A Cellular Look at COPD
COPD consists of distinct cellular micro-environments rather than a single uniform disease.
Read More
Secondhand Vape Plumes Could Form Lung-damaging Radicals
A chemical cocktail of metal nanoparticles and reactive peroxides in aged e-cigarette aerosols creates a unique profile of respiratory health risks.
Read More